In nanodiamond-treated animals, the overwhelming presence of CD44+CD62 L+ memory T cells makes a significant difference in pathology and limits tumor growth, while untreated animals have loads of CD44+ T cells in lymphoid organs such as the spleen. This evidence concerns the gene CD44 and neoplasm.